Discovery of Potent, Selective, CNS-Penetrant Macrocyclic LRRK2 Inhibitors for the Treatment of Parkinson’s Disease
1. 当前求助状态已完结, 请及时下载应助文件
2. 系统将在 2026-04-06 22:44:57 删除文件
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI: https://doi.org/10.1021/acs.jmedchem.6c00238
文献链接: https://pubs.acs.org/doi/10.1021/acs.jmedchem.6c00238
其他信息:
出版社: American Chemical Society (ACS)
作者: Elsie C. Yu; Hua Zhou; Xin Yan; Kaitlyn M. Logan; Derun Li; Anmol Gulati; Kelsey E. Poremba; Michael J. Ardolino; Jing Su; Dong Xiao; Rachel L. Palte; Spencer E. McMinn; Lisa M. Nogle; Donovon A. Adpressa; Samantha A. Burgess; Tina Xiong; Karin M. Otte; Harry R. Chobanian; Alan Bass; Susi Lee; Kara Pearson; Eric Messina; Michael Parisi; John Barnum; Zhanna Sobol; Paul J. Ciaccio; Erin F. DiMauro; Matthew J. Fell; Peter H. Fuller
全文下载地址: https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.6c00238
